产后阿片类药物使用障碍康复技术干预的可行性研究。

IF 0.6 4区 医学 Q2 Social Sciences
Anna Beth Parlier-Ahmad, Lillia Thumma, Sarah Martin, Michelle Eglovitch, Kameron Simmons, Tiffany Kimbrough, Dace S Svikis, Caitlin E Martin
{"title":"产后阿片类药物使用障碍康复技术干预的可行性研究。","authors":"Anna Beth Parlier-Ahmad, Lillia Thumma, Sarah Martin, Michelle Eglovitch, Kameron Simmons, Tiffany Kimbrough, Dace S Svikis, Caitlin E Martin","doi":"10.1080/1067828x.2024.2447774","DOIUrl":null,"url":null,"abstract":"<p><p>This randomized feasibility trial aimed to 1) assess methodology for a subsequent efficacy trial and 2) examine the usability and acceptability of Project BETTER's hybrid technology-delivered educational intervention for pregnant people receiving medication for opioid use disorder within a perinatal addiction treatment clinic. Participants were randomized to the technology-delivered educational intervention or standard practice control (brochure). Project BETTER's intervention offers three modules (pregnancy-to-postpartum transition, Neonatal Opioid Withdrawal Syndrome, child welfare interactions) via Computerized Intervention Authoring System (CIAS 3.0). Inclusion criteria were: ≥18 years of age, <34 weeks pregnant, currently receiving medication for opioid use disorder (MOUD), and had engaged in care ≤10 weeks during their current pregnancy. Study visits included an online survey, brief interview, and medical record review. Mean perceived helpfulness scores were compared by study condition using independent samples t-test. The screening process identified 49 potential participants, n=31 (63%) of whom were recruited. Twenty-nine participants were randomized (intervention: n=16, control: n=13). Participants (n=29) were reproductive age [M = 30.0 years (SD = 4.4)], 66% white and 31% Black with a median estimated gestational age of 24 weeks. Most participants (69%) received buprenorphine. Study completion rate was 83%. Most participants completed study components remotely. Among participants in the intervention group, 56% completed at least one module. Participants perceived the intervention to be as helpful as the brochure (intervention: 5.28 ± 0.98, control: 5.39 ± 0.56, p=0.387) and highly acceptable. With protocol modifications, scale up to a larger clinical trial is feasible and acceptable to pregnant people receiving MOUD.</p>","PeriodicalId":46463,"journal":{"name":"JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE","volume":"30 2","pages":"52-63"},"PeriodicalIF":0.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12338197/pdf/","citationCount":"0","resultStr":"{\"title\":\"Feasibility trial of a technology-delivered intervention for opioid use disorder recovery postpartum.\",\"authors\":\"Anna Beth Parlier-Ahmad, Lillia Thumma, Sarah Martin, Michelle Eglovitch, Kameron Simmons, Tiffany Kimbrough, Dace S Svikis, Caitlin E Martin\",\"doi\":\"10.1080/1067828x.2024.2447774\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This randomized feasibility trial aimed to 1) assess methodology for a subsequent efficacy trial and 2) examine the usability and acceptability of Project BETTER's hybrid technology-delivered educational intervention for pregnant people receiving medication for opioid use disorder within a perinatal addiction treatment clinic. Participants were randomized to the technology-delivered educational intervention or standard practice control (brochure). Project BETTER's intervention offers three modules (pregnancy-to-postpartum transition, Neonatal Opioid Withdrawal Syndrome, child welfare interactions) via Computerized Intervention Authoring System (CIAS 3.0). Inclusion criteria were: ≥18 years of age, <34 weeks pregnant, currently receiving medication for opioid use disorder (MOUD), and had engaged in care ≤10 weeks during their current pregnancy. Study visits included an online survey, brief interview, and medical record review. Mean perceived helpfulness scores were compared by study condition using independent samples t-test. The screening process identified 49 potential participants, n=31 (63%) of whom were recruited. Twenty-nine participants were randomized (intervention: n=16, control: n=13). Participants (n=29) were reproductive age [M = 30.0 years (SD = 4.4)], 66% white and 31% Black with a median estimated gestational age of 24 weeks. Most participants (69%) received buprenorphine. Study completion rate was 83%. Most participants completed study components remotely. Among participants in the intervention group, 56% completed at least one module. Participants perceived the intervention to be as helpful as the brochure (intervention: 5.28 ± 0.98, control: 5.39 ± 0.56, p=0.387) and highly acceptable. With protocol modifications, scale up to a larger clinical trial is feasible and acceptable to pregnant people receiving MOUD.</p>\",\"PeriodicalId\":46463,\"journal\":{\"name\":\"JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE\",\"volume\":\"30 2\",\"pages\":\"52-63\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12338197/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/1067828x.2024.2447774\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Social Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/1067828x.2024.2447774","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Social Sciences","Score":null,"Total":0}
引用次数: 0

摘要

这项随机可行性试验旨在1)评估后续疗效试验的方法,2)检查BETTER项目的混合技术提供的教育干预的可用性和可接受性,该干预针对围产期成瘾治疗诊所接受阿片类药物使用障碍药物治疗的孕妇。参与者被随机分配到技术提供的教育干预或标准实践控制(小册子)。BETTER项目的干预通过计算机化干预创作系统(CIAS 3.0)提供三个模块(妊娠至产后过渡、新生儿阿片类药物戒断综合征、儿童福利互动)。纳入标准为:≥18岁;
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Feasibility trial of a technology-delivered intervention for opioid use disorder recovery postpartum.

This randomized feasibility trial aimed to 1) assess methodology for a subsequent efficacy trial and 2) examine the usability and acceptability of Project BETTER's hybrid technology-delivered educational intervention for pregnant people receiving medication for opioid use disorder within a perinatal addiction treatment clinic. Participants were randomized to the technology-delivered educational intervention or standard practice control (brochure). Project BETTER's intervention offers three modules (pregnancy-to-postpartum transition, Neonatal Opioid Withdrawal Syndrome, child welfare interactions) via Computerized Intervention Authoring System (CIAS 3.0). Inclusion criteria were: ≥18 years of age, <34 weeks pregnant, currently receiving medication for opioid use disorder (MOUD), and had engaged in care ≤10 weeks during their current pregnancy. Study visits included an online survey, brief interview, and medical record review. Mean perceived helpfulness scores were compared by study condition using independent samples t-test. The screening process identified 49 potential participants, n=31 (63%) of whom were recruited. Twenty-nine participants were randomized (intervention: n=16, control: n=13). Participants (n=29) were reproductive age [M = 30.0 years (SD = 4.4)], 66% white and 31% Black with a median estimated gestational age of 24 weeks. Most participants (69%) received buprenorphine. Study completion rate was 83%. Most participants completed study components remotely. Among participants in the intervention group, 56% completed at least one module. Participants perceived the intervention to be as helpful as the brochure (intervention: 5.28 ± 0.98, control: 5.39 ± 0.56, p=0.387) and highly acceptable. With protocol modifications, scale up to a larger clinical trial is feasible and acceptable to pregnant people receiving MOUD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
3
期刊介绍: The Journal of Child & Adolescent Substance Abuse addresses the treatment of substance abuse in all ages of children. With the growing magnitude of the problem of substance abuse among children and youth, this is an essential forum for the dissemination of descriptive or investigative efforts with this population. The journal serves as a vehicle for communication and dissemination of information to the many practitioners and researchers working with these young people. With this singular mission in mind, the Journal of Child & Adolescent Substance Abuse provides subscribers with one source for obtaining current, useful information regarding state-of-the-art approaches to the strategies and issues in the assessment, prevention, and treatment of adolescent substance abuse.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信